How North Texas Kickstarted the Telemedicine Revolution

Almost 15 years ago, a pair of entrepreneurs launched a telemedicine company in North Dallas that tried to monetize treating low acuity conditions over the phone. Teladoc built a physician base and targeted large employers, offering bridge services to employees when they couldn’t get into the doctor’s office for their cold or urinary tract infection or pink eye. Last year, Teladoc became the only telemedicine company to be publicly traded on the New York Stock Exchange. It posted annual revenue of $77 million in 2015, a year-over-year increase of 78 percent. And it’s also found itself in the middle of a national discussion on how telehealth services should be regulated. Just how much access is still safe for patients? Full Story

Teladoc Misses Earnings Projections In Q3, But Boosts Revenue, Visits, Subscriptions

The telemedicine provider recorded $32.4 million in revenue for the quarter, an increase of 62 percent compared to the same period in 2015. As is standard with the company, the revenue was primarily made up of subscription access fees ($27.8 million, up from $17 million in 2015) and visit fees ($4.6 million, up from $3 million). Full Story

Survey: Nearly Three Quarters of Physicians Say They Haven’t Seen ROI From Electronic Records

About three-quarters of physicians who have invested in an electronic health record system report not having seen a return on their investment. That’s according to findings in Physician Practice magazine’s first ever technology report, which contains results from 1,568 physicians, mid-levels, and practice administrators across the country, 63.3 percent of whom are independent. About 28 percent were employed by a system. Full Story

Children’s Health Adopts Ingestible Microchip Technology

Children’s Health has begun offering patients an ingestible microchip and digital patch that can track whether an individual takes his or her medicine and monitors their diagnostics afterward. The technology is part of the health system’s initiative to expand its telehealth programs and bolster the portfolio of its investment arm, which now includes four companies. Full Story